Value proposition

Cell therapy Acceleration and Innovation: Rethinking cell & gene therapy
By Institut Curie

CellAction (Cell therapy Acceleration and Innovation) is the cell and gene therapy platform of the Paris-Saclay Cancer Cluster (PSCC) at Institut Curie. A first in France, CellAction enables collaborative projects to be launched with industrial partners on a national and international scale. The aim is to accelerate the development of optimized cell and gene therapies.

CellAction is founded on the centralization of key expertise required for the drug development process:

- Institut Curie's highly qualified medical-scientific teams
- Cutting-edge technologies for in vitro and in vivo testing
- Experienced advisors on business development and processes.

This integrated structure makes it possible to launch projects for the development of innovative cell and gene therapies, from basic research through to their transfer to the clinic and delivery to patients.

Oncologie, Innovation, Thérapies géniques, Thérapies cellulaires, Recherche, and Santé